Canada - English - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - alemtuzumab - solution - 30mg - alemtuzumab 30mg - antineoplastic agents

Canada - English - Health Canada

hoffmann-la roche limited - obinutuzumab - solution - 25mg - obinutuzumab 25mg - antineoplastic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - ofatumumab - solution - 100mg - ofatumumab 100mg - antineoplastic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - ofatumumab - solution - 1000mg - ofatumumab 1000mg - antineoplastic agents

Singapore - English - HSA (Health Sciences Authority)

eisai (singapore) pte. ltd. - bendamustine hydrocloride 100mg (equivalent to bendamustine 90.8 mg) - injection, powder, lyophilized, for solution - 100mg - bendamustine hydrocloride 100mg (equivalent to bendamustine 90.8 mg) 100mg

Singapore - English - HSA (Health Sciences Authority)

eisai (singapore) pte. ltd. - bendamustine hydrocloride 25mg (equivalent to bendamustine 22.7mg) - injection, powder, lyophilized, for solution - 25 mg - bendamustine hydrocloride 25mg (equivalent to bendamustine 22.7mg) 25 mg

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - obinutuzumab - infusion, solution concentrate - obinutuzumab 1000 mg/40 ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roche (malaysia) sdn. bhd. - obinutuzumab -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - ofatumumab - solution for infusion - 20mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - ofatumumab - solution for infusion - 20mg/1ml